Search
CELL BANK Website

Back Back
RCB2099 : TE-10  update : 2018/08/02
CommentHuman cell line derived from esophageal cancer. Highly differentiated squamous cell carcinoma. TKG0261 (Deposited from Tohoku Univ.).
Comment from the depositor
Terms and conditionsA prior written permission of the approver(Originator) is necessary for any kind of use including academic use and for-profit use.
Remarks
approver's address
×
English
Address
Koseikai Hospital

320-1 Yamada, Kawagoe city, Saitama 350-8588, Japan
Dr.Nishihira, Tetsuro
Fax. +81-49-223-5713
Order Form Regarding MTA between user institutions and RIKEN BRC, there are two kinds of MTA, Category I and II, depending on the sort of user institutions and the purposes of use.Please use an appropriate MTA(to see).In case of Restriction "a" or "f", please contact RIKEN BRC(cellbank.brc@riken.jp) regarding any kind of for-profit use.
Basic information Depositor Obinata, Masuo
Originator Nishihira, Tetsuro
Year of deposit 2005
Original cell TKG0261
Animal human < Mammals
Genus Homo
Species sapiens
Tissue esophagus
Case history Highly differntiated squamous carcinoma
Classification cancer
History Cell Resource Center for Biomedical Research, Tohoku University(TKG0261)
Lifespan infinite
Morphology epithelial-like
deposit info
lot info
Medium Medium List
Culture type Adherent cells
Medium and additives RPMI1640 + 10% FBS
Antibiotics Free
Passage method 0.25% trypsin
Culture information Passage ratio 1 : 8 split
SC frequency Subculture : 2 times/week
Temperature 37 ℃
CO2 concentration 5 %
Freeze medium Medium + 10% DMSO
Freezing method Slow freezing
Mycoplasma (-)
STR (human) OK
Isozyme LD, NP
Images
deposit info
lot info
Reference information Reference 0
User's Publication 21


To topTop
Reference

To topTop
User's Publication
7225  Inhibition of Rho-associated kinases disturbs the collective cell migration of stratified TE-10 cells.  Mikami T, Yoshida K, Sawada H, Esaki M, Yasumura K, Ono M.  Biol. Res.  2015  48:48  PubMed ID: 26330114
7327  miR-27 is associated with chemoresistance in esophageal cancer through transformation of normal fibroblasts to cancer-associated fibroblasts.  Tanaka K, Miyata H, Sugimura K, Fukuda S, Kanemura T, Yamashita K, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Wada H, Nakajima K, Takiguchi S, Mori M, Doki Y.  Carcinogenesis  2015  36:894-903  PubMed ID: 26026166
7350  Interleukin-32 expression and Treg infiltration in esophageal squamous cell carcinoma.  Nabeki B, Ishigami S, Uchikado Y, Sasaki K, Kita Y, Okumura H, Arigami T, Kijima Y, Kurahara H, Maemura K, Natsugoe S.  Anticancer Res.  2015  35:2941-7  PubMed ID: 25964580
7382  The role of HGF/MET and FGF/FGFR in fibroblast-derived growth stimulation and lapatinib-resistance of esophageal squamous cell carcinoma.  Saito S, Morishima K, Ui T, Hoshino H, Matsubara D, Ishikawa S, Aburatani H, Fukayama M, Hosoya Y, Sata N, Lefor AK, Yasuda Y, Niki T.  BMC Cancer  2015  15:82  PubMed ID: 25884729
9599  Novel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinoma.  Kikuchi O, Ohashi S, Horibe T, Kohno M, Nakai Y, Miyamoto S, Chiba T, Muto M, Kawakami K.  Sci Rep  2016  6:22452  PubMed ID: 26956916
9724  Overexpression of glypican-1 implicates poor prognosis and their chemoresistance in oesophageal squamous cell carcinoma.  Hara H, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Nakatsuka R, Harada E, Nishigaki T, Takahashi Y, Nojima S, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Takiguchi S, Morii E, Mori M, Doki Y, Naka T.  Br. J. Cancer  2016  115:66-75  PubMed ID: 27310703
10004  Downregulation of ST6GALNAC1 is associated with esophageal squamous cell carcinoma development.  Iwaya T, Sawada G, Amano S, Kume K, Ito C, Endo F, Konosu M, Shioi Y, Akiyama Y, Takahara T, Otsuka K, Nitta H, Koeda K, Mizuno M, Nishizuka S, Sasaki A, Mimori K.  Int. J. Oncol.  2017  50:441-447  PubMed ID: 28035351
10141  Suppressor of cytokine signaling-1 gene therapy induces potent antitumor effect in patient-derived esophageal squamous cell carcinoma xenograft mice.  Sugase T, Takahashi T, Serada S, Nakatsuka R, Fujimoto M, Ohkawara T, Hara H, Nishigaki T, Tanaka K, Miyazaki Y, Makino T, Kurokawa Y, Yamasaki M, Nakajima K, Takiguchi S, Kishimoto T, Mori M, Doki Y, Naka T.  Int. J. Cancer  2017  140:2608-2621  PubMed ID: 28233302
10353  Overexpression of TRIM44 is related to invasive potential and malignant outcomes in esophageal squamous cell carcinoma.  Kawaguchi T, Komatsu S, Ichikawa D, Hirajima S, Nishimura Y, Konishi H, Shiozaki A, Fujiwara H, Okamoto K, Tsuda H, Otsuji E.  Tumour Biol.  2017  39:1010428317700409  PubMed ID: 28618928
10365  Poly (ADP-ribose) polymerase-1 inhibition decreases proliferation through G2/M arrest in esophageal squamous cell carcinoma.  Yamamoto M, Yamasaki M, Tsukao Y, Tanaka K, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.  Oncol Lett  2017  14:1581-1587  PubMed ID: 28789382
10798  Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.  Shinno N, Kimura H, Sada R, Takiguchi S, Mori M, Fumoto K, Doki Y, Kikuchi A.  Oncogene  2018  37(26):3471-3484  PubMed ID: 29563607
10892  RXDX-107, A Dodecanol Alkyl Ester of Bendamustine, Demonstrates Greater Stability and Broad Antitumor Activity in Multiple Pre-Clinical Models of Solid Tumor    Chemo Open Access  2016  5:3 
11092  Biphasic regulation of tumorigenesis by PTK7 expression level in esophageal squamous cell carcinoma.  Shin WS, Gim J, Won S, Lee ST.  Sci Rep  2018  8(1):8519  PubMed ID: 29867084
11369  An actin-binding protein ESPN is an independent prognosticator and regulates cell growth for esophageal squamous cell carcinoma.  Li SH, Lu HI, Huang WT, Chen YH, Lo CM, Lan YC, Lin WC, Tsai HT, Chen CH.  Cancer Cell Int.  2018    PubMed ID: 30618491
4355  PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.  Furukawa H, Makino T, Yamasaki M, Tanaka K, Miyazaki Y, Takahashi T, Kurokawa Y, Nakajima K, Takiguchi S, Mori M, Doki Y.  Cancer Sci.  2018  109(2):412-421  PubMed ID: 29168598
4357  Oncogenic IL7R is downregulated by histone deacetylase inhibitor in esophageal squamous cell carcinoma via modulation of acetylated FOXO1.  Kim MJ, Choi SK, Hong SH, Eun JW, Nam SW, Han JW, You JS.  Int. J. Oncol.  2018  53(1):395-403  PubMed ID: 29749437
4504  B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.  Piao L, Yang Z, Jin J, Ni W, Qi W, Xuan Y.  Hum. Pathol.  2018  80:152-162  PubMed ID: 29885401
4505  Identification of LETM1 as a marker of cancer stem-like cells and predictor of poor prognosis in esophageal squamous cell carcinoma.  Yang Z, Ni W, Cui C, Qi W, Piao L, Xuan Y.  Hum. Pathol.  2018  81:148-156  PubMed ID: 30031102
11526  Cyclin-Dependent Kinase Inhibitor 3 Promoted Cell Proliferation by Driving Cell Cycle from G1 to S Phase in Esophageal Squamous Cell Carcinoma.  Liu J, Min L, Zhu S, Guo Q, Li H, Zhang Z, Zhao Y, Xu C, Zhang S.  J Cancer  2019    PubMed ID: 31205550
11791  Catalytically inactive receptor tyrosine kinase PTK7 activates FGFR1 independent of FGF.  Shin WS, Lee HW, Lee ST.  FASEB J.  2019    PubMed ID: 31490704
6410  Is parainfluenza virus a threatening virus for human cancer cell lines?  Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.  Hum Cell  2009  22(3):81-4  PubMed ID: 19624309



Back Back Return Top Page